NCT01449162View on ClinicalTrials.gov

Masitinib in Treatment of Patients With Severe Persistent Asthma Treated With Oral Corticosteroids

PHASE3CompletedINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Asthma
Interventions
DRUG

Masitinib

6 mg/kg/day

DRUG

Placebo

Trial Locations (8)

4032

University of Debrecen Medical and Health Science Center, Debrecen

5800

Dr. Georgi Stranski University Hospital, Pleven

29609

Hospital La Cavale Blanche, Brest

46017

Hospital Universitario Doctor Peset, Valencia

69317

l'Hopital de la Croix Rousse, Lyon

500068

King George Hospital, Hyderabad

Unknown

Hospital Polyclinic Melnik, Mělník

l'Hopital Albert Calmette, Lille

Sponsors

Lead Sponsor

AB Science
All Listed Sponsors
lead

AB Science

INDUSTRY